Global Microbiomes Market Growth (Status and Outlook) 2022-2028

Publisher Name :
Date: 11-Feb-2022
No. of pages: 124

As the global economy mends, the 2021 growth of Microbiomes will have significant change from previous year. According to our (LP Information) latest study, the global Microbiomes market size is USD million in 2022 from USD 522.6 million in 2021, with a change of % between 2021 and 2022. The global Microbiomes market size will reach USD 2076.3 million in 2028, growing at a CAGR of 21.8% over the analysis period.

The United States Microbiomes market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Microbiomes market, reaching US$ million by the year 2028. As for the Europe Microbiomes landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.

Global main Microbiomes players cover 4D Pharma, Enterome BioScience, Evelo Biosciences, and Ferring, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.

This report presents a comprehensive overview, market shares, and growth opportunities of Microbiomes market by product type, application, key players and key regions and countries.

Segmentation by type: breakdown data from 2017 to 2022 in Section 2.3; and forecast to 2028 in section 10.7.

- Gastrointestinal Microbiome

- Genitourinary Microbiome

- Skin Microbiome

- Respiratory Microbiome

- Other

Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 10.8.

- Testing

- Treatment

- Diagnosis

- Technology Platform

- Probiotics

- Other

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.

- Americas

- - United States

- - Canada

- - Mexico

- - Brazil

- APAC

- - China

- - Japan

- - Korea

- - Southeast Asia

- - India

- - Australia

- Europe

- - Germany

- - France

- - UK

- - Italy

- - Russia

- Middle East & Africa

- - Egypt

- - South Africa

- - Israel

- - Turkey

- - GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major players in the market. The key players covered in this report: Breakdown data in in Chapter 3.

- 4D Pharma

- Enterome BioScience

- Evelo Biosciences

- Ferring

- Osel

- Second Genome

- Seres Therapeutics

- Synlogic

- Synthetic Biologics and Vedanta Biosciences

- Vedanta

- Rebiotix

- ActoGeniX

- Enterologics

- Metabogen

- Metabiomics

- Ritter Pharmaceuticals

- AvidBiotics

- Symberix

- Miomics

- Symbiotix Biotherapies

- MicroBiome Therapeutics LLC

- SciBac Inc

Global Microbiomes Market Growth (Status and Outlook) 2022-2028

Table of Contents

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Microbiomes Market Size 2017-2028
2.1.2 Microbiomes Market Size CAGR by Region 2017 VS 2022 VS 2028
2.2 Microbiomes Segment by Type
2.2.1 Gastrointestinal Microbiome
2.2.2 Genitourinary Microbiome
2.2.3 Skin Microbiome
2.2.4 Respiratory Microbiome
2.2.5 Other
2.3 Microbiomes Market Size by Type
2.3.1 Microbiomes Market Size CAGR by Type (2017 VS 2022 VS 2028)
2.3.2 Global Microbiomes Market Size Market Share by Type (2017-2022)
2.4 Microbiomes Segment by Application
2.4.1 Testing
2.4.2 Treatment
2.4.3 Diagnosis
2.4.4 Technology Platform
2.4.5 Probiotics
2.4.6 Other
2.5 Microbiomes Market Size by Application
2.5.1 Microbiomes Market Size CAGR by Application (2017 VS 2022 VS 2028)
2.5.2 Global Microbiomes Market Size Market Share by Application (2017-2022)
3 Microbiomes Market Size by Player
3.1 Microbiomes Market Size Market Share by Players
3.1.1 Global Microbiomes Revenue by Players (2020-2022)
3.1.2 Global Microbiomes Revenue Market Share by Players (2020-2022)
3.2 Global Microbiomes Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Microbiomes by Regions
4.1 Microbiomes Market Size by Regions (2017-2022)
4.2 Americas Microbiomes Market Size Growth (2017-2022)
4.3 APAC Microbiomes Market Size Growth (2017-2022)
4.4 Europe Microbiomes Market Size Growth (2017-2022)
4.5 Middle East & Africa Microbiomes Market Size Growth (2017-2022)
5 Americas
5.1 Americas Microbiomes Market Size by Country (2017-2022)
5.2 Americas Microbiomes Market Size by Type (2017-2022)
5.3 Americas Microbiomes Market Size by Application (2017-2022)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Microbiomes Market Size by Region (2017-2022)
6.2 APAC Microbiomes Market Size by Type (2017-2022)
6.3 APAC Microbiomes Market Size by Application (2017-2022)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Microbiomes by Country (2017-2022)
7.2 Europe Microbiomes Market Size by Type (2017-2022)
7.3 Europe Microbiomes Market Size by Application (2017-2022)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Microbiomes by Region (2017-2022)
8.2 Middle East & Africa Microbiomes Market Size by Type (2017-2022)
8.3 Middle East & Africa Microbiomes Market Size by Application (2017-2022)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Global Microbiomes Market Forecast
10.1 Global Microbiomes Forecast by Regions (2023-2028)
10.1.1 Global Microbiomes Forecast by Regions (2023-2028)
10.1.2 Americas Microbiomes Forecast
10.1.3 APAC Microbiomes Forecast
10.1.4 Europe Microbiomes Forecast
10.1.5 Middle East & Africa Microbiomes Forecast
10.2 Americas Microbiomes Forecast by Country (2023-2028)
10.2.1 United States Microbiomes Market Forecast
10.2.2 Canada Microbiomes Market Forecast
10.2.3 Mexico Microbiomes Market Forecast
10.2.4 Brazil Microbiomes Market Forecast
10.3 APAC Microbiomes Forecast by Region (2023-2028)
10.3.1 China Microbiomes Market Forecast
10.3.2 Japan Microbiomes Market Forecast
10.3.3 Korea Microbiomes Market Forecast
10.3.4 Southeast Asia Microbiomes Market Forecast
10.3.5 India Microbiomes Market Forecast
10.3.6 Australia Microbiomes Market Forecast
10.4 Europe Microbiomes Forecast by Country (2023-2028)
10.4.1 Germany Microbiomes Market Forecast
10.4.2 France Microbiomes Market Forecast
10.4.3 UK Microbiomes Market Forecast
10.4.4 Italy Microbiomes Market Forecast
10.4.5 Russia Microbiomes Market Forecast
10.5 Middle East & Africa Microbiomes Forecast by Region (2023-2028)
10.5.1 Egypt Microbiomes Market Forecast
10.5.2 South Africa Microbiomes Market Forecast
10.5.3 Israel Microbiomes Market Forecast
10.5.4 Turkey Microbiomes Market Forecast
10.5.5 GCC Countries Microbiomes Market Forecast
10.6 Global Microbiomes Forecast by Type (2023-2028)
10.7 Global Microbiomes Forecast by Application (2023-2028)

11 Key Players Analysis
11.1 4D Pharma
11.1.1 4D Pharma Company Information
11.1.2 4D Pharma Microbiomes Product Offered
11.1.3 4D Pharma Microbiomes Revenue, Gross Margin and Market Share (2020-2022)
11.1.4 4D Pharma Main Business Overview
11.1.5 4D Pharma Latest Developments
11.2 Enterome BioScience
11.2.1 Enterome BioScience Company Information
11.2.2 Enterome BioScience Microbiomes Product Offered
11.2.3 Enterome BioScience Microbiomes Revenue, Gross Margin and Market Share (2020-2022)
11.2.4 Enterome BioScience Main Business Overview
11.2.5 Enterome BioScience Latest Developments
11.3 Evelo Biosciences
11.3.1 Evelo Biosciences Company Information
11.3.2 Evelo Biosciences Microbiomes Product Offered
11.3.3 Evelo Biosciences Microbiomes Revenue, Gross Margin and Market Share (2020-2022)
11.3.4 Evelo Biosciences Main Business Overview
11.3.5 Evelo Biosciences Latest Developments
11.4 Ferring
11.4.1 Ferring Company Information
11.4.2 Ferring Microbiomes Product Offered
11.4.3 Ferring Microbiomes Revenue, Gross Margin and Market Share (2020-2022)
11.4.4 Ferring Main Business Overview
11.4.5 Ferring Latest Developments
11.5 Osel
11.5.1 Osel Company Information
11.5.2 Osel Microbiomes Product Offered
11.5.3 Osel Microbiomes Revenue, Gross Margin and Market Share (2020-2022)
11.5.4 Osel Main Business Overview
11.5.5 Osel Latest Developments
11.6 Second Genome
11.6.1 Second Genome Company Information
11.6.2 Second Genome Microbiomes Product Offered
11.6.3 Second Genome Microbiomes Revenue, Gross Margin and Market Share (2020-2022)
11.6.4 Second Genome Main Business Overview
11.6.5 Second Genome Latest Developments
11.7 Seres Therapeutics
11.7.1 Seres Therapeutics Company Information
11.7.2 Seres Therapeutics Microbiomes Product Offered
11.7.3 Seres Therapeutics Microbiomes Revenue, Gross Margin and Market Share (2020-2022)
11.7.4 Seres Therapeutics Main Business Overview
11.7.5 Seres Therapeutics Latest Developments
11.8 Synlogic
11.8.1 Synlogic Company Information
11.8.2 Synlogic Microbiomes Product Offered
11.8.3 Synlogic Microbiomes Revenue, Gross Margin and Market Share (2020-2022)
11.8.4 Synlogic Main Business Overview
11.8.5 Synlogic Latest Developments
11.9 Synthetic Biologics and Vedanta Biosciences
11.9.1 Synthetic Biologics and Vedanta Biosciences Company Information
11.9.2 Synthetic Biologics and Vedanta Biosciences Microbiomes Product Offered
11.9.3 Synthetic Biologics and Vedanta Biosciences Microbiomes Revenue, Gross Margin and Market Share (2020-2022)
11.9.4 Synthetic Biologics and Vedanta Biosciences Main Business Overview
11.9.5 Synthetic Biologics and Vedanta Biosciences Latest Developments
11.10 Vedanta
11.10.1 Vedanta Company Information
11.10.2 Vedanta Microbiomes Product Offered
11.10.3 Vedanta Microbiomes Revenue, Gross Margin and Market Share (2020-2022)
11.10.4 Vedanta Main Business Overview
11.10.5 Vedanta Latest Developments
11.11 Rebiotix
11.11.1 Rebiotix Company Information
11.11.2 Rebiotix Microbiomes Product Offered
11.11.3 Rebiotix Microbiomes Revenue, Gross Margin and Market Share (2020-2022)
11.11.4 Rebiotix Main Business Overview
11.11.5 Rebiotix Latest Developments
11.12 ActoGeniX
11.12.1 ActoGeniX Company Information
11.12.2 ActoGeniX Microbiomes Product Offered
11.12.3 ActoGeniX Microbiomes Revenue, Gross Margin and Market Share (2020-2022)
11.12.4 ActoGeniX Main Business Overview
11.12.5 ActoGeniX Latest Developments
11.13 Enterologics
11.13.1 Enterologics Company Information
11.13.2 Enterologics Microbiomes Product Offered
11.13.3 Enterologics Microbiomes Revenue, Gross Margin and Market Share (2020-2022)
11.13.4 Enterologics Main Business Overview
11.13.5 Enterologics Latest Developments
11.14 Metabogen
11.14.1 Metabogen Company Information
11.14.2 Metabogen Microbiomes Product Offered
11.14.3 Metabogen Microbiomes Revenue, Gross Margin and Market Share (2020-2022)
11.14.4 Metabogen Main Business Overview
11.14.5 Metabogen Latest Developments
11.15 Metabiomics
11.15.1 Metabiomics Company Information
11.15.2 Metabiomics Microbiomes Product Offered
11.15.3 Metabiomics Microbiomes Revenue, Gross Margin and Market Share (2020-2022)
11.15.4 Metabiomics Main Business Overview
11.15.5 Metabiomics Latest Developments
11.16 Ritter Pharmaceuticals
11.16.1 Ritter Pharmaceuticals Company Information
11.16.2 Ritter Pharmaceuticals Microbiomes Product Offered
11.16.3 Ritter Pharmaceuticals Microbiomes Revenue, Gross Margin and Market Share (2020-2022)
11.16.4 Ritter Pharmaceuticals Main Business Overview
11.16.5 Ritter Pharmaceuticals Latest Developments
11.17 AvidBiotics
11.17.1 AvidBiotics Company Information
11.17.2 AvidBiotics Microbiomes Product Offered
11.17.3 AvidBiotics Microbiomes Revenue, Gross Margin and Market Share (2020-2022)
11.17.4 AvidBiotics Main Business Overview
11.17.5 AvidBiotics Latest Developments
11.18 Symberix
11.18.1 Symberix Company Information
11.18.2 Symberix Microbiomes Product Offered
11.18.3 Symberix Microbiomes Revenue, Gross Margin and Market Share (2020-2022)
11.18.4 Symberix Main Business Overview
11.18.5 Symberix Latest Developments
11.19 Miomics
11.19.1 Miomics Company Information
11.19.2 Miomics Microbiomes Product Offered
11.19.3 Miomics Microbiomes Revenue, Gross Margin and Market Share (2020-2022)
11.19.4 Miomics Main Business Overview
11.19.5 Miomics Latest Developments
11.20 Symbiotix Biotherapies
11.20.1 Symbiotix Biotherapies Company Information
11.20.2 Symbiotix Biotherapies Microbiomes Product Offered
11.20.3 Symbiotix Biotherapies Microbiomes Revenue, Gross Margin and Market Share (2020-2022)
11.20.4 Symbiotix Biotherapies Main Business Overview
11.20.5 Symbiotix Biotherapies Latest Developments
11.21 MicroBiome Therapeutics LLC
11.21.1 MicroBiome Therapeutics LLC Company Information
11.21.2 MicroBiome Therapeutics LLC Microbiomes Product Offered
11.21.3 MicroBiome Therapeutics LLC Microbiomes Revenue, Gross Margin and Market Share (2020-2022)
11.21.4 MicroBiome Therapeutics LLC Main Business Overview
11.21.5 MicroBiome Therapeutics LLC Latest Developments
11.22 SciBac Inc
11.22.1 SciBac Inc Company Information
11.22.2 SciBac Inc Microbiomes Product Offered
11.22.3 SciBac Inc Microbiomes Revenue, Gross Margin and Market Share (2020-2022)
11.22.4 SciBac Inc Main Business Overview
11.22.5 SciBac Inc Latest Developments
12 Research Findings and Conclusion

List of Tables
Table 1. Microbiomes Market Size CAGR by Region (2017 VS 2022 VS 2028) & ($ Millions)
Table 2. Major Players of Gastrointestinal Microbiome
Table 3. Major Players of Genitourinary Microbiome
Table 4. Major Players of Skin Microbiome
Table 5. Major Players of Respiratory Microbiome
Table 6. Major Players of Other
Table 7. Microbiomes Market Size CAGR by Type (2017 VS 2022 VS 2028) & ($ Millions)
Table 8. Global Microbiomes Market Size by Type (2017-2022) & ($ Millions)
Table 9. Global Microbiomes Market Size Market Share by Type (2017-2022)
Table 10. Microbiomes Market Size CAGR by Application (2017 VS 2022 VS 2028) & ($ Millions)
Table 11. Global Microbiomes Market Size by Application (2017-2022) & ($ Millions)
Table 12. Global Microbiomes Market Size Market Share by Application (2017-2022)
Table 13. Global Microbiomes Revenue by Players (2020-2022) & ($ Millions)
Table 14. Global Microbiomes Revenue Market Share by Player (2020-2022)
Table 15. Microbiomes Key Players Head office and Products Offered
Table 16. Microbiomes Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 17. New Products and Potential Entrants
Table 18. Mergers & Acquisitions, Expansion
Table 19. Global Microbiomes Market Size by Regions 2017-2022 & ($ Millions)
Table 20. Global Microbiomes Market Size Market Share by Regions (2017-2022)
Table 21. Americas Microbiomes Market Size by Country (2017-2022) & ($ Millions)
Table 22. Americas Microbiomes Market Size Market Share by Country (2017-2022)
Table 23. Americas Microbiomes Market Size by Type (2017-2022) & ($ Millions)
Table 24. Americas Microbiomes Market Size Market Share by Type (2017-2022)
Table 25. Americas Microbiomes Market Size by Application (2017-2022) & ($ Millions)
Table 26. Americas Microbiomes Market Size Market Share by Application (2017-2022)
Table 27. APAC Microbiomes Market Size by Region (2017-2022) & ($ Millions)
Table 28. APAC Microbiomes Market Size Market Share by Region (2017-2022)
Table 29. APAC Microbiomes Market Size by Type (2017-2022) & ($ Millions)
Table 30. APAC Microbiomes Market Size Market Share by Type (2017-2022)
Table 31. APAC Microbiomes Market Size by Application (2017-2022) & ($ Millions)
Table 32. APAC Microbiomes Market Size Market Share by Application (2017-2022)
Table 33. Europe Microbiomes Market Size by Country (2017-2022) & ($ Millions)
Table 34. Europe Microbiomes Market Size Market Share by Country (2017-2022)
Table 35. Europe Microbiomes Market Size by Type (2017-2022) & ($ Millions)
Table 36. Europe Microbiomes Market Size Market Share by Type (2017-2022)
Table 37. Europe Microbiomes Market Size by Application (2017-2022) & ($ Millions)
Table 38. Europe Microbiomes Market Size Market Share by Application (2017-2022)
Table 39. Middle East & Africa Microbiomes Market Size by Region (2017-2022) & ($ Millions)
Table 40. Middle East & Africa Microbiomes Market Size Market Share by Region (2017-2022)
Table 41. Middle East & Africa Microbiomes Market Size by Type (2017-2022) & ($ Millions)
Table 42. Middle East & Africa Microbiomes Market Size Market Share by Type (2017-2022)
Table 43. Middle East & Africa Microbiomes Market Size by Application (2017-2022) & ($ Millions)
Table 44. Middle East & Africa Microbiomes Market Size Market Share by Application (2017-2022)
Table 45. Key Market Drivers & Growth Opportunities of Microbiomes
Table 46. Key Market Challenges & Risks of Microbiomes
Table 47. Key Industry Trends of Microbiomes
Table 48. Global Microbiomes Market Size Forecast by Regions (2023-2028) & ($ Millions)
Table 49. Global Microbiomes Market Size Market Share Forecast by Regions (2023-2028)
Table 50. Global Microbiomes Market Size Forecast by Type (2023-2028) & ($ Millions)
Table 51. Global Microbiomes Market Size Market Share Forecast by Type (2023-2028)
Table 52. Global Microbiomes Market Size Forecast by Application (2023-2028) & ($ Millions)
Table 53. Global Microbiomes Market Size Market Share Forecast by Application (2023-2028)
Table 54. 4D Pharma Details, Company Type, Microbiomes Area Served and Its Competitors
Table 55. 4D Pharma Microbiomes Product Offered
Table 56. 4D Pharma Microbiomes Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 57. 4D Pharma Main Business
Table 58. 4D Pharma Latest Developments
Table 59. Enterome BioScience Details, Company Type, Microbiomes Area Served and Its Competitors
Table 60. Enterome BioScience Microbiomes Product Offered
Table 61. Enterome BioScience Main Business
Table 62. Enterome BioScience Microbiomes Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 63. Enterome BioScience Latest Developments
Table 64. Evelo Biosciences Details, Company Type, Microbiomes Area Served and Its Competitors
Table 65. Evelo Biosciences Microbiomes Product Offered
Table 66. Evelo Biosciences Main Business
Table 67. Evelo Biosciences Microbiomes Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 68. Evelo Biosciences Latest Developments
Table 69. Ferring Details, Company Type, Microbiomes Area Served and Its Competitors
Table 70. Ferring Microbiomes Product Offered
Table 71. Ferring Main Business
Table 72. Ferring Microbiomes Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 73. Ferring Latest Developments
Table 74. Osel Details, Company Type, Microbiomes Area Served and Its Competitors
Table 75. Osel Microbiomes Product Offered
Table 76. Osel Main Business
Table 77. Osel Microbiomes Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 78. Osel Latest Developments
Table 79. Second Genome Details, Company Type, Microbiomes Area Served and Its Competitors
Table 80. Second Genome Microbiomes Product Offered
Table 81. Second Genome Main Business
Table 82. Second Genome Microbiomes Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 83. Second Genome Latest Developments
Table 84. Seres Therapeutics Details, Company Type, Microbiomes Area Served and Its Competitors
Table 85. Seres Therapeutics Microbiomes Product Offered
Table 86. Seres Therapeutics Main Business
Table 87. Seres Therapeutics Microbiomes Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 88. Seres Therapeutics Latest Developments
Table 89. Synlogic Details, Company Type, Microbiomes Area Served and Its Competitors
Table 90. Synlogic Microbiomes Product Offered
Table 91. Synlogic Main Business
Table 92. Synlogic Microbiomes Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 93. Synlogic Latest Developments
Table 94. Synthetic Biologics and Vedanta Biosciences Details, Company Type, Microbiomes Area Served and Its Competitors
Table 95. Synthetic Biologics and Vedanta Biosciences Microbiomes Product Offered
Table 96. Synthetic Biologics and Vedanta Biosciences Main Business
Table 97. Synthetic Biologics and Vedanta Biosciences Microbiomes Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 98. Synthetic Biologics and Vedanta Biosciences Latest Developments
Table 99. Vedanta Details, Company Type, Microbiomes Area Served and Its Competitors
Table 100. Vedanta Microbiomes Product Offered
Table 101. Vedanta Main Business
Table 102. Vedanta Microbiomes Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 103. Vedanta Latest Developments
Table 104. Rebiotix Details, Company Type, Microbiomes Area Served and Its Competitors
Table 105. Rebiotix Microbiomes Product Offered
Table 106. Rebiotix Microbiomes Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 107. Rebiotix Main Business
Table 108. Rebiotix Latest Developments
Table 109. ActoGeniX Details, Company Type, Microbiomes Area Served and Its Competitors
Table 110. ActoGeniX Microbiomes Product Offered
Table 111. ActoGeniX Main Business
Table 112. ActoGeniX Microbiomes Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 113. ActoGeniX Latest Developments
Table 114. Enterologics Details, Company Type, Microbiomes Area Served and Its Competitors
Table 115. Enterologics Microbiomes Product Offered
Table 116. Enterologics Main Business
Table 117. Enterologics Microbiomes Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 118. Enterologics Latest Developments
Table 119. Metabogen Details, Company Type, Microbiomes Area Served and Its Competitors
Table 120. Metabogen Microbiomes Product Offered
Table 121. Metabogen Main Business
Table 122. Metabogen Microbiomes Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 123. Metabogen Latest Developments
Table 124. Metabiomics Details, Company Type, Microbiomes Area Served and Its Competitors
Table 125. Metabiomics Microbiomes Product Offered
Table 126. Metabiomics Main Business
Table 127. Metabiomics Microbiomes Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 128. Metabiomics Latest Developments
Table 129. Ritter Pharmaceuticals Details, Company Type, Microbiomes Area Served and Its Competitors
Table 130. Ritter Pharmaceuticals Microbiomes Product Offered
Table 131. Ritter Pharmaceuticals Main Business
Table 132. Ritter Pharmaceuticals Microbiomes Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 133. Ritter Pharmaceuticals Latest Developments
Table 134. AvidBiotics Details, Company Type, Microbiomes Area Served and Its Competitors
Table 135. AvidBiotics Microbiomes Product Offered
Table 136. AvidBiotics Main Business
Table 137. AvidBiotics Microbiomes Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 138. AvidBiotics Latest Developments
Table 139. Symberix Details, Company Type, Microbiomes Area Served and Its Competitors
Table 140. Symberix Microbiomes Product Offered
Table 141. Symberix Main Business
Table 142. Symberix Microbiomes Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 143. Symberix Latest Developments
Table 144. Miomics Details, Company Type, Microbiomes Area Served and Its Competitors
Table 145. Miomics Microbiomes Product Offered
Table 146. Miomics Main Business
Table 147. Miomics Microbiomes Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 148. Miomics Latest Developments
Table 149. Symbiotix Biotherapies Details, Company Type, Microbiomes Area Served and Its Competitors
Table 150. Symbiotix Biotherapies Microbiomes Product Offered
Table 151. Symbiotix Biotherapies Main Business
Table 152. Symbiotix Biotherapies Microbiomes Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 153. Symbiotix Biotherapies Latest Developments
Table 154. MicroBiome Therapeutics LLC Details, Company Type, Microbiomes Area Served and Its Competitors
Table 155. MicroBiome Therapeutics LLC Microbiomes Product Offered
Table 156. MicroBiome Therapeutics LLC Microbiomes Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 157. MicroBiome Therapeutics LLC Main Business
Table 158. MicroBiome Therapeutics LLC Latest Developments
Table 159. SciBac Inc Details, Company Type, Microbiomes Area Served and Its Competitors
Table 160. SciBac Inc Microbiomes Product Offered
Table 161. SciBac Inc Main Business
Table 162. SciBac Inc Microbiomes Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 163. SciBac Inc Latest Developments
List of Figures
Figure 1. Microbiomes Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Microbiomes Market Size Growth Rate 2017-2028 ($ Millions)
Figure 6. Global Microbiomes Market Size Market Share by Type in 2021
Figure 7. Microbiomes in Testing
Figure 8. Global Microbiomes Market: Testing (2017-2022) & ($ Millions)
Figure 9. Microbiomes in Treatment
Figure 10. Global Microbiomes Market: Treatment (2017-2022) & ($ Millions)
Figure 11. Microbiomes in Diagnosis
Figure 12. Global Microbiomes Market: Diagnosis (2017-2022) & ($ Millions)
Figure 13. Microbiomes in Technology Platform
Figure 14. Global Microbiomes Market: Technology Platform (2017-2022) & ($ Millions)
Figure 15. Microbiomes in Probiotics
Figure 16. Global Microbiomes Market: Probiotics (2017-2022) & ($ Millions)
Figure 17. Microbiomes in Other
Figure 18. Global Microbiomes Market: Other (2017-2022) & ($ Millions)
Figure 19. Global Microbiomes Market Size Market Share by Application in 2021
Figure 20. Global Microbiomes Revenue Market Share by Player in 2021
Figure 21. Global Microbiomes Market Size Market Share by Regions (2017-2022)
Figure 22. Americas Microbiomes Market Size 2017-2022 ($ Millions)
Figure 23. APAC Microbiomes Market Size 2017-2022 ($ Millions)
Figure 24. Europe Microbiomes Market Size 2017-2022 ($ Millions)
Figure 25. Middle East & Africa Microbiomes Market Size 2017-2022 ($ Millions)
Figure 26. Americas Microbiomes Value Market Share by Country in 2021
Figure 27. Americas Microbiomes Consumption Market Share by Type in 2021
Figure 28. Americas Microbiomes Market Size Market Share by Application in 2021
Figure 29. United States Microbiomes Market Size Growth 2017-2022 ($ Millions)
Figure 30. Canada Microbiomes Market Size Growth 2017-2022 ($ Millions)
Figure 31. Mexico Microbiomes Market Size Growth 2017-2022 ($ Millions)
Figure 32. Brazil Microbiomes Market Size Growth 2017-2022 ($ Millions)
Figure 33. APAC Microbiomes Market Size Market Share by Region in 2021
Figure 34. APAC Microbiomes Market Size Market Share by Application in 2021
Figure 35. China Microbiomes Market Size Growth 2017-2022 ($ Millions)
Figure 36. Japan Microbiomes Market Size Growth 2017-2022 ($ Millions)
Figure 37. Korea Microbiomes Market Size Growth 2017-2022 ($ Millions)
Figure 38. Southeast Asia Microbiomes Market Size Growth 2017-2022 ($ Millions)
Figure 39. India Microbiomes Market Size Growth 2017-2022 ($ Millions)
Figure 40. Australia Microbiomes Market Size Growth 2017-2022 ($ Millions)
Figure 41. Europe Microbiomes Market Size Market Share by Country in 2021
Figure 42. Europe Microbiomes Market Size Market Share by Type in 2021
Figure 43. Europe Microbiomes Market Size Market Share by Application in 2021
Figure 44. Germany Microbiomes Market Size Growth 2017-2022 ($ Millions)
Figure 45. France Microbiomes Market Size Growth 2017-2022 ($ Millions)
Figure 46. UK Microbiomes Market Size Growth 2017-2022 ($ Millions)
Figure 47. Italy Microbiomes Market Size Growth 2017-2022 ($ Millions)
Figure 48. Russia Microbiomes Market Size Growth 2017-2022 ($ Millions)
Figure 49. Middle East & Africa Microbiomes Market Size Market Share by Region in 2021
Figure 50. Middle East & Africa Microbiomes Market Size Market Share by Type in 2021
Figure 51. Middle East & Africa Microbiomes Market Size Market Share by Application in 2021
Figure 52. Egypt Microbiomes Market Size Growth 2017-2022 ($ Millions)
Figure 53. South Africa Microbiomes Market Size Growth 2017-2022 ($ Millions)
Figure 54. Israel Microbiomes Market Size Growth 2017-2022 ($ Millions)
Figure 55. Turkey Microbiomes Market Size Growth 2017-2022 ($ Millions)
Figure 56. GCC Country Microbiomes Market Size Growth 2017-2022 ($ Millions)
Figure 57. Americas Microbiomes Market Size 2023-2028 ($ Millions)
Figure 58. APAC Microbiomes Market Size 2023-2028 ($ Millions)
Figure 59. Europe Microbiomes Market Size 2023-2028 ($ Millions)
Figure 60. Middle East & Africa Microbiomes Market Size 2023-2028 ($ Millions)
Figure 61. United States Microbiomes Market Size 2023-2028 ($ Millions)
Figure 62. Canada Microbiomes Market Size 2023-2028 ($ Millions)
Figure 63. Mexico Microbiomes Market Size 2023-2028 ($ Millions)
Figure 64. Brazil Microbiomes Market Size 2023-2028 ($ Millions)
Figure 65. China Microbiomes Market Size 2023-2028 ($ Millions)
Figure 66. Japan Microbiomes Market Size 2023-2028 ($ Millions)
Figure 67. Korea Microbiomes Market Size 2023-2028 ($ Millions)
Figure 68. Southeast Asia Microbiomes Market Size 2023-2028 ($ Millions)
Figure 69. India Microbiomes Market Size 2023-2028 ($ Millions)
Figure 70. Australia Microbiomes Market Size 2023-2028 ($ Millions)
Figure 71. Germany Microbiomes Market Size 2023-2028 ($ Millions)
Figure 72. France Microbiomes Market Size 2023-2028 ($ Millions)
Figure 73. UK Microbiomes Market Size 2023-2028 ($ Millions)
Figure 74. Italy Microbiomes Market Size 2023-2028 ($ Millions)
Figure 75. Russia Microbiomes Market Size 2023-2028 ($ Millions)
Figure 76. Spain Microbiomes Market Size 2023-2028 ($ Millions)
Figure 77. Egypt Microbiomes Market Size 2023-2028 ($ Millions)
Figure 78. South Africa Microbiomes Market Size 2023-2028 ($ Millions)
Figure 79. Israel Microbiomes Market Size 2023-2028 ($ Millions)
Figure 80. Turkey Microbiomes Market Size 2023-2028 ($ Millions)
Figure 81. GCC Countries Microbiomes Market Size 2023-2028 ($ Millions)
  • Global Nuclear Medicine Cyclotron Systems Market Report, History and Forecast 2018-2029
    Published: 11-Jan-2024        Price: US 3350 Onwards        Pages: 118
    The global Nuclear Medicine Cyclotron Systems market was valued at US$ 220.85 million in 2022 and will reach US$ 283.75 million by the end of 2029, growing at a CAGR of 4.38% during 2023-2029. Asia-Pacific market for Nuclear Medicine Cyclotron Systems was valued at $ 61.16 million in 2022 and will reach $ 104.22 million by 2029, at a CAGR of 5.84% during the forecast period of 2023 through 2029. Report Scope This report aims to provide a comprehensive presentation of the glo......
  • Global Non-imaging Diagnostic Catheter Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 95
    The global Non-imaging Diagnostic Catheter market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......
  • Global Imaging Diagnostic Catheter Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 90
    The global Imaging Diagnostic Catheter market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estimated......
  • Global PCR Equipment Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 77
    The global PCR Equipment market was valued at US$ 806 million in 2023 and is anticipated to reach US$ 1230.7 million by 2030, witnessing a CAGR of 6.7% during The forecast period 2024-2030. PCR (Polymerase Chain Reaction) equipment is widely used in molecular biology and genetics research for amplifying DNA and RNA sequences. The market for PCR equipment is influenced by several key drivers. Here are some of The significant market drivers: Advancements in Research and Diagnost......
  • Global Disposable Sterile Syringes and Needles Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 109
    The global Disposable Sterile Syringes and Needles market was valued at US$ 404.4 million in 2023 and is anticipated to reach US$ 539.1 million by 2030, witnessing a CAGR of 2.1% during The forecast period 2024-2030. North American market for Disposable Sterile Syringes and Needles is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Disposable Sterile Syringes and N......
  • Global Orthopaedic Power Tools Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106
    The global Orthopaedic Power Tools market was valued at US$ 463.3 million in 2023 and is anticipated to reach US$ 746.5 million by 2030, witnessing a CAGR of 7.3% during The forecast period 2024-2030. North American market for Orthopaedic Power Tools is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Orthopaedic Power Tools is estimated to increase from $ million i......
  • Global Cerebrospinal Fluid Management Devices Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86
    The global Cerebrospinal Fluid Management Devices market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Cerebrospinal Fluid Management Devices is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Cerebrospinal Fluid Management Devices is estimate......
  • Global CAD & CAM Milling Burs Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 79
    The global CAD & CAM Milling Burs market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for CAD & CAM Milling Burs is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for CAD & CAM Milling Burs is estimated to increase from $ million in 2023 to reach $ ......
  • Global Artificial Teeth Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 98
    The global Artificial Teeth market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Artificial Teeth is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Artificial Teeth is estimated to increase from $ million in 2023 to reach $ million by 2030, a......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs